Conference Coverage
Conference Coverage
08/13/2026
Brittany Watson, MD, MPH; Joseph Mikhael, MD, MEd, FRCPC
In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...
08/13/2026
FAQ
doctor talking to patient
FAQ
08/10/2026
Primary care physicians can help identify previously unrecognized hemophilia B, respond appropriately to bleeding and procedural risks, reinforce hematology-directed treatment plans, and support patients...
08/10/2026
FDA Approval
FDA Approval
08/07/2026
Anthony Calabro, MA
The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.
08/07/2026
Research Summary
Research Summary
08/06/2026
Ashton L. Stahl
A US prescription claims study evaluated uptake and 2-year persistence among users of long-acting injectable cabotegravir for HIV PrEP.
08/06/2026
research summary
research summary
07/29/2026
Anthony Calabro, MA
In a 12-month pragmatic RCT of 300 patients aged ≥1 year with physician-diagnosed atopic dermatitis, an online, team-based connected health teledermatology model produced equivalent quality-of-life...
07/29/2026
Research Summary
Research Summary
07/17/2026
Kate Young
In two pragmatic randomized trials conducted in the Capital Region of Denmark, investigators compared collaborative care with consultation liaison in general practice to assess whether greater involvement...
07/17/2026
Research Summary
Research Summary
07/08/2026
Kate Young
A randomized clinical trial evaluating 2 types of 1-page educational resources for low back pain found that fact sheets listing treatment options modestly improved patients’ preparedness for shared...
07/08/2026
FDA Approval
FDA Approval
06/30/2026
Anthony Calabro, MA
The FDA approved tebipenem pivoxil (Utebzi) for adults with complicated urinary tract infections, including pyelonephritis, who have limited or no alternative oral treatment options.
06/30/2026
Research Summary
Research Summary
06/30/2026
Anthony Calabro, MA
In an international Bayesian adaptive RCT of adults with MSSA bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin for 90-day all-cause mortality and was associated with less acute kidney...
06/30/2026
FDA Approval
FDA Approval
06/25/2026
Anthony Calabro, MA
The FDA approved expanded adjuvant therapy options for adults with renal cell carcinoma with a clear cell component who are at intermediate-high or high risk of recurrence after nephrectomy, with or without...
06/25/2026